PubRank

Osamu Honmou

Author PubWeight™ 35.89‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A therapeutic window for intravenous administration of autologous bone marrow after cerebral ischemia in adult rats. Brain Res 2004 2.11
2 Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model. Mol Ther 2005 1.91
3 BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model. Mol Ther 2004 1.87
4 Remyelination of the spinal cord following intravenous delivery of bone marrow cells. Glia 2002 1.68
5 Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy. Cancer Sci 2005 1.68
6 BDNF-hypersecreting human mesenchymal stem cells promote functional recovery, axonal sprouting, and protection of corticospinal neurons after spinal cord injury. J Neurosci 2009 1.40
7 Mesenchymal stem cells derived from peripheral blood protects against ischemia. J Neurotrauma 2007 1.33
8 Telomerized human multipotent mesenchymal cells can differentiate into hematopoietic and cobblestone area-supporting cells. Exp Hematol 2003 1.29
9 Intravenous administration of glial cell line-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat. J Neurosci Res 2006 1.27
10 Intravenous administration of mesenchymal stem cells derived from bone marrow after contusive spinal cord injury improves functional outcome. Brain Res 2010 1.22
11 Therapeutic benefits by human mesenchymal stem cells (hMSCs) and Ang-1 gene-modified hMSCs after cerebral ischemia. J Cereb Blood Flow Metab 2007 1.21
12 A quantitative morphometric analysis of rat spinal cord remyelination following transplantation of allogenic Schwann cells. J Comp Neurol 2002 1.20
13 Therapeutic benefits of angiogenetic gene-modified human mesenchymal stem cells after cerebral ischemia. Exp Neurol 2008 1.08
14 Optimization of a therapeutic protocol for intravenous injection of human mesenchymal stem cells after cerebral ischemia in adult rats. Brain Res 2008 1.08
15 Therapeutic time window of mesenchymal stem cells derived from bone marrow after cerebral ischemia. Brain Res 2010 1.05
16 Comparative analysis of remyelinating potential of focal and intravenous administration of autologous bone marrow cells into the rat demyelinated spinal cord. Glia 2003 1.04
17 Therapeutic benefits of human mesenchymal stem cells derived from bone marrow after global cerebral ischemia. Brain Res 2009 0.99
18 Neural differentiation potential of peripheral blood- and bone-marrow-derived precursor cells. Brain Res 2006 0.96
19 Mesenchymal stem cells transmigrate across brain microvascular endothelial cell monolayers through transiently formed inter-endothelial gaps. Neurosci Lett 2011 0.95
20 Development of a middle cerebral artery occlusion model in the nonhuman primate and a safety study of i.v. infusion of human mesenchymal stem cells. PLoS One 2011 0.93
21 Bone marrow stem cells in experimental stroke. Prog Brain Res 2012 0.90
22 Autologous transplantation of expanded neural precursor cells into the demyelinated monkey spinal cord. Brain Res 2004 0.89
23 A rat middle cerebral artery occlusion model and intravenous cellular delivery. Methods Mol Biol 2009 0.88
24 Expression of aquaporin-4 augments cytotoxic brain edema after traumatic brain injury during acute ethanol exposure. Am J Pathol 2011 0.87
25 Remyelination after olfactory ensheathing cell transplantation into diverse demyelinating environments. Exp Neurol 2011 0.86
26 Identification of chemoattractive factors involved in the migration of bone marrow-derived mesenchymal stem cells to brain lesions caused by prions. J Virol 2011 0.85
27 Magnetic resonance lactate and lipid signals in rat brain after middle cerebral artery occlusion model. Brain Res 2006 0.84
28 Effect of transplantation of bone marrow-derived mesenchymal stem cells on mice infected with prions. J Virol 2009 0.83
29 Prior ethanol injection promotes brain edema after traumatic brain injury. J Neurotrauma 2009 0.81
30 Bilateral cortical hyperactivity detected by fMRI associates with improved motor function following intravenous infusion of mesenchymal stem cells in a rat stroke model. Brain Res 2012 0.81
31 Therapeutic effects of human mesenchymal and hematopoietic stem cells on rotenone-treated parkinsonian mice. J Neurosci Res 2012 0.78
32 Optimization of three-dimensional time-of-flight magnetic resonance angiography of the intracranial arteries. Neurol Med Chir (Tokyo) 2006 0.76
33 [Phase III clinical trial using autologous mesenchymal stem cells for stroke patients]. Nihon Rinsho 2016 0.75
34 T2 reversed fast spin-echo image and enhanced three-dimensional surface MR angiography for the diagnosis of cerebral arteriovenous malformations. J Clin Neurosci 2002 0.75
35 [Bone marrow stem cell therapy for stroke]. Nihon Rinsho 2011 0.75
36 [111In-DTPA cisterno SPECT for the diagnosis of CSF rhinorrhea: case report]. No Shinkei Geka 2002 0.75
37 Spinal cord infarct as the initial clinical presentation of intravascular malignant lymphomatosis. J Clin Neurosci 2009 0.75
38 [Treatment of cerebral ischemia using mesenchymal stem cell-clinical trial phase III]. Nihon Jibiinkoka Gakkai Kaiho 2015 0.75